Description
- Type your response into the message field to the following discussion prompt:
Clinical prevention trials have shown that specific agents can reduce the risk of different cancer types: Discuss two examples of clinical trials with impressive results for cancer prevention.
Read your classmates’ messages and post at least one reply by the end of the week.
for reply
MAHA
Clinical prevention trials have provided strong evidence that certain pharmacological agents can significantly reduce the risk of developing specific types of cancer. These trials are particularly important because they focus on preventing cancer before it occurs, rather than treating it after diagnosis. Two of the most impressive examples include the use of tamoxifen for breast cancer prevention and aspirin for colorectal cancer prevention.
One landmark trial in cancer prevention is the NSABP P-1 Breast Cancer Prevention Trial, which investigated the role of tamoxifen in women at high risk for breast cancer. The results demonstrated that tamoxifen reduced the incidence of invasive estrogen receptor–positive breast cancer by approximately 50%. This outcome was especially significant because it provided the first strong clinical evidence that a selective estrogen receptor modulator could be used effectively for cancer prevention, not just treatment. From a clinical perspective, this trial reshaped preventive strategies for high-risk women and highlighted the importance of balancing benefits with potential risks such as thromboembolic events.
Another notable example is the long-term follow-up of large randomized trials evaluating aspirin use for colorectal cancer prevention, including the Physicians’ Health Study and other pooled analyses. These studies showed that regular, low-dose aspirin use was associated with a meaningful reduction in colorectal cancer incidence and mortality, particularly after extended use of 5–10 years. The impressive aspect of these findings lies in the fact that aspirin is widely available, inexpensive, and already used for cardiovascular prevention, making it a practical option for population-level cancer prevention when appropriately prescribed.
Together, these trials illustrate how well-designed clinical prevention studies can translate biological understanding into real-world public health benefits. They also emphasize the importance of personalized risk assessment, as preventive agents must be carefully matched to individuals who are most likely to benefit while minimizing potential harm.
References
– Fisher, B., Costantino, J. P., Wickerham, D. L., et al. (1998). *Tamoxifen for prevention of breast cancer: Report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study*. Journal of the National Cancer Institute, 90(18), 1371–1388.
-Rothwell, P. M., Wilson, M., Elwin, C. E., et al. (2010). *Long-term effect of aspirin on colorectal cancer incidence and mortality*. The Lancet, 376(9754), 1741–1750.
– Cuzick, J., Otto, F., Baron, J. A., et al. (2009). *Aspirin and non-steroidal anti-inflammatory drugs for cancer prevention: An international consensus statement*. The Lancet Oncology, 10(5), 501–507.
Bottom of Form
ADNAN
Top of Form
Tamoxifen is an example of a clinical trial conducted to prevent the development of breast cancer in women with a high risk of developing cancer. Results of multiple large clinical trials have demonstrated that women who receive tamoxifen for several years have a 40% to 50% lower incidence of breast cancer than women who do not receive tamoxifen. The significance of this finding is that tamoxifen can be used for both prevention and treatment of breast cancer. Similarly, there is substantial evidence from clinical trials assessing the efficacy of the HPV vaccine as a method of preventing the human papillomavirus (HPV) infection that is responsible for the majority of cervical cancers. The results of the numerous clinical trials from many countries indicate that there is a significant reduction in the incidence of HPV infections and precancerous cervical cell changes among young women who are vaccinated against HPV. As a result of these findings, many nations have implemented HPV vaccination programs with the goal of reducing cervical cancer rates in future generations. Therefore, clinical preventative research trials provide credibility that cancer can be prevented; many countries recognize the importance of prevention in reducing suffering, medical expenses, and death as well as promoting healthier lifestyles for individuals. Thus, research and effective cancer preventative strategies are essential to combating cancer on a global scale.
Ref:
Britt, K. L., Cuzick, J., & Phillips, K. A. (2020). Key steps for effective breast cancer prevention. Nature Reviews Cancer, 20(8), 417-436.
